UiPath Slides to 52-Week Low as AI Fears Mount

NEW YORK, May 1 —

UiPath (PATH) closed the week at $10.30, a fresh 52-week low for the automation software vendor and roughly 25% below the $13.81 average Wall Street price target. Retail investors are calling the selloff "irrational." The tape is calling it something else: a bet that generative AI labs are about to eat the robotic process automation business alive.

The Anthropic Trade

The narrative driving PATH lower is easy to summarize and harder to dismiss: if a frontier model can read a screen, click a button, and fill out a form, what exactly is UiPath selling? Coverage in Quiver Quantitative explicitly tied the recent weakness to "Anthropic Competition Fears" alongside the Q4 print. MSN picked up the retail counter-narrative — that the selloff is "irrational" — but the price action suggests the marginal seller doesn't agree.

That's the bear case in one paragraph. The complication is that RPA was never just about clicking buttons. It's about governance, audit trails, integration with legacy enterprise systems, and the unglamorous work of making automations that don't break when SAP pushes a patch. A general-purpose AI agent can mimic the demo. Whether it can survive a SOX audit is a different question, and one the market hasn't fully answered yet.

The Outlook Cut That Set the Tone

The damage didn't start this week. UiPath filed an 8-K on March 11 reporting Q4 results of operations and financial condition, and TipRanks summed up the reaction with a headline that didn't leave much to interpretation: "UiPath Stock Sinks as Outlook Cut Shocks Investors." Two weeks later, on March 25, a second 8-K disclosed a departure or appointment of directors or principal officers under Item 5.02, paired with a Regulation FD disclosure.

An outlook cut followed by a board or officer change in two weeks is not a coincidence the market tends to ignore. Whether the personnel move was reactive or already in motion, the optical sequencing reinforced the bearish read.

What the Bears Are Missing

Strip away the AI panic and the financial profile is unusual for a stock trading like a structurally impaired business. Revenue grew 13.6% on a trailing basis. Gross margin is 83.2% — software economics, not services economics. Free cash flow over the trailing twelve months was $474 million, which on a $5.4 billion market cap is an FCF yield north of 8%. The forward P/E of 11.5x prices PATH closer to a mature industrial than a mid-cycle software company.

The earnings cadence backs the cash flow up. UiPath has beaten consensus EPS in each of its last four reported quarters, including $0.11 against $0.10, $0.15 against $0.08, and $0.16 against $0.15. Those aren't blowouts, but they aren't the misses you'd expect from a company being structurally displaced. A business getting eaten by AI agents tends to miss on revenue and guide down on margins. UiPath is doing neither — yet.

The Databricks Hedge

Then there's the late-April announcement that complicates the "RPA is obsolete" narrative. UiPath linked Databricks data with its AI workflows for real-time action, a deal covered by both Stock Titan and Quiver Quantitative. The strategic logic is straightforward: if the future of automation is agentic AI operating on enterprise data, sitting inside the data plane where that data already lives is a defensible place to be.

It's not a moat. It is, however, evidence that management is not waiting around to be disrupted. The Databricks tie-up reads as a recognition that the next generation of automation will be model-driven, not script-driven, and that UiPath's enterprise distribution is worth more if it ships with AI baked in. The market, fixated on the Anthropic threat, has assigned this announcement roughly zero credit.

The Insider Footnote

A casual look at the Form 4 filings could mislead. On April 1, four senior officers — COO and CFO Ashim Gupta, General Counsel Brad Brubaker, CPO and CTO Raghavendra Malpani, and Chief Accounting Officer Hitesh Ramani — each received equity grants and disposed of shares at $11.10. Gupta picked up 306,748 shares and had 49,063 and 30,526 shares withheld for taxes. Brubaker received 157,208 with 24,842 and 30,442 withheld. Malpani took 159,125; Ramani 123,466. CEO and Chairman Daniel Dines filed three Form 4s on March 16 each tagged "Other" and each involving 9,615,297 shares.

The disposals look bigger than they are. Per the filings, the $544,599 and $338,839 sales by Gupta and the comparable lots from the other officers were tax-withholding on grant vesting, not discretionary selling. Open-market purchases over the last 90 days totaled zero. Open-market sales totaled zero. The takeaway is that insider activity here is mechanical compensation plumbing, not an information signal in either direction. Anyone reading the gross disposal numbers as a "vote of no confidence" is reading the wrong column of the spreadsheet.

What to Watch

The next checkpoint is UiPath's First Quarter Fiscal 2027 financial results conference call, the date of which the company has already announced via release. That print is the test of whether the cut outlook was a one-quarter reset or the start of a deceleration. Three things will tell the story:

First, net retention. If existing customers are pulling back on automation seats because they're waiting to see what Anthropic ships, that shows up here before it shows up in revenue. Second, AI-related bookings. Management needs to demonstrate that the Databricks integration and broader AI workflow positioning is translating into pipeline, not press releases. Third, free cash flow. The $474 million trailing figure is the load-bearing wall under the valuation; if FCF compresses meaningfully, the 11.5x forward multiple loses its safety net.

The honest read is that this is genuinely two-sided. The bearish signals — the 52-week low, the outlook cut, persistent AI competition fears — are real. The bullish offsets — double-digit revenue growth at 83% gross margins, an 8%-plus FCF yield, four straight EPS beats, and a Databricks integration that suggests management sees what's coming — are also real. The market has chosen its side. Whether that's prescient or premature is the bet.

Run the free UiPath, Inc. deep-dive →

Basis Report does not hold positions in securities discussed. This is not investment advice.

Frequently Asked Questions

Why is UiPath stock at a 52-week low?

Investors are pricing in competitive pressure from Anthropic and other AI labs, compounded by a recently cut outlook flagged after the March 11 Q4 release. As detailed above, the selling has pushed PATH to $10.30 against a $13.81 analyst target.

Did UiPath insiders sell stock recently?

Several officers including the CFO and General Counsel had shares withheld at $11.10 on April 1, but per the Form 4 filings these were tax-withholding dispositions on vesting grants, not open-market sales. Open-market buying and selling over the last 90 days both totaled zero.

What is the UiPath Databricks partnership?

UiPath linked Databricks data with its AI workflows for real-time action in late April, per Stock Titan and Quiver Quantitative coverage. The article explains why the move matters strategically given the Anthropic competition narrative.

Is UiPath profitable?

UiPath generated $474 million in trailing twelve-month free cash flow on $1.61 billion in revenue, and has beaten consensus EPS estimates in each of its last four reported quarters. The valuation context is covered in detail above.

When does UiPath report next earnings?

UiPath has announced its First Quarter Fiscal 2027 financial results conference call, per a release picked up by Stock Titan. The article outlines the three metrics that will determine whether the cut outlook was a one-time reset.